Indivior (INDV)

 

Latest News

RBP-6000 Investor Event

RNS Number: 2638I Indivior PLC 16 June 2017 Indivior to Host Investor Event on RBP-6000 on June 29that 12:00 Noon EDT US (5:00 P.M. UK Time) Slough, UK, and Richmond, VA, June 16th, 2017 - Indivior PLC (LON: INDV) today announced that it will host an investor presentation on RBP-6000, its once monthly injectable buprenorphine which is being developed ...

Block Listing Six Monthly Return

RNS Number: 9854G Indivior PLC 02 June 2017 BLOCK LISTING SIX MONTHLY RETURN Date: June 2, 2017 Name of applicant: INDIVIOR PLC Name of scheme: U.S. EMPLOYEE STOCK PURCHASE PLAN Period of return: From: DECEMBER 2, 2016 To: JUNE 1, 2017 Balance of unallotted securities under scheme(s) from previous return: 1,500,000 ORDINAR...

Total Voting Rights

RNS Number: 9092G Indivior PLC 01 June 2017 Indivior PLC - Total Voting Rights and Capital In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, Indivior PLC (the 'Company') hereby notifies the market that as at June 1, 2017 the Company's issued share capital consisted of 720,988,383 O rdinary Shares of US$0.10 each. The Company does n...

RBP-6000 - Submission of NDA to U.S. FDA

RNS Number: 6059G Indivior PLC 30 May 2017 Indivior Submits New Drug Application to U.S. FDA for RBP-6000 Buprenorphine Monthly Depot A Potential Novel Long-Acting, Sustained-Release Product Candidate for Treatment of Opioid Use Disorder Slough, UK, 30 May 2017 - Indivior PLC (LON: INDV) (the 'Company') today announced that the Company has ...

All News

DateHeadlineSource
16-06-17RBP-6000 Investor EventRNS
02-06-17Block Listing Six Monthly ReturnRNS
01-06-17Total Voting RightsRNS
30-05-17RBP-6000 - Submission of NDA to U.S. FDARNS
23-05-17Jefferies Global Healthcare ConferenceRNS
18-05-17Indivior resolutions passed at AGMStockMarketWire
17-05-17Result of AGMRNS
03-05-17Indivior Q1 profit, revenue up in Q1StockMarketWire
03-05-171st Quarter ResultsRNS
19-04-17Indivior schedules Q1 results announcementStockMarketWire
19-04-17Notice of ResultsRNS
07-04-17Holding(s) in CompanyRNS
28-03-17Additional RBP-6000 Clinical Study ResultsRNS
23-03-17Indivior sets date for AGMStockMarketWire
23-03-17Annual Financial ReportRNS
13-03-17Top-line Phase 3 Trial Results - RBP-7000RNS
13-03-17Broker Forecast - RBC Capital Markets issues a broker note on Indivior PlcStockMarketWire
08-03-17Indivior CFO steps down StockMarketWire
07-03-17Director ResignationRNS
02-03-17Broker Forecast - Citigroup issues a broker note on Indivior PlcStockMarketWire
27-02-17Director Deals - Indivior Plc (INDV)StockMarketWire
27-02-17Director Deals - Indivior Plc (INDV)StockMarketWire
27-02-17Director Deals - Indivior Plc (INDV)StockMarketWire
27-02-17Director Deals - Indivior Plc (INDV)StockMarketWire
27-02-17Director Deals - Indivior Plc (INDV)StockMarketWire
27-02-17Director Deals - Indivior Plc (INDV)StockMarketWire
27-02-17Director Deals - Indivior Plc (INDV)StockMarketWire
27-02-17Director Deals - Indivior Plc (INDV)StockMarketWire
27-02-17Director/PDMR ShareholdingRNS
27-02-17Director/PDMR ShareholdingRNS
27-02-17Broker Forecast - Jefferies International issues a broker note on Indivior PlcStockMarketWire
22-02-17Indivior net revenues rise StockMarketWire
22-02-17Directorate ChangeRNS
22-02-17Full Year Financial ResultsRNS
15-02-17Director DeclarationRNS
14-02-17Holding(s) in CompanyRNS
13-02-17Holding(s) in CompanyRNS
10-02-17Holding(s) in CompanyRNS
09-02-17Holding(s) in CompanyRNS
06-02-17Indivior schedules FY resultsStockMarketWire

RSS feeds

  • Editorial news feed for LSE:INDV Editorial
  • Regulatory news feed for LSE:INDV Regulatory